REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/08/2025
Back to search
Official data from USPTO
CPIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/09/2025
Trademark type
Word
Nice classes
35, 42
Filing date
10/09/2015
Registration date
06/07/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2023
Last transaction
06/09/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2010-03-00
First use in commerce
2010-03-00
Drawing code
4
Owner type
99
Owner location
Bethesda, MD
Examiner
FIONDA,LAURA ELIZABETH
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
U.S. Department of Health and Human Services
Representatives
Angela Y. Dai Office Of The General Counsel
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Association servicesorganization of a consortium for the purpose of optimization of drug therapy results in the treatment of human diseases based on genetic information; promoting collaboration within the biomedical research communities to develop and achieve improved drug therapy results based on genetic information and providing related information about opportunities to participate in such research; promoting the interests of the biomedical research communities by organizing groups and partnerships for the purpose of optimization of drug therapy results in the treatment of human diseases based on genetic information
Class 42
Development of peer-reviewed guidelines to optimize drug therapy results based on genetic information; scientific research for medical purposes in the field of pharmacogenomics
Publications
History of USPTO decisions and trademark events.
15 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/05/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/22/2016
PUBO
PUBLISHED FOR OPPOSITION
03/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2016
DOCK
ASSIGNED TO EXAMINER
02/01/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
10/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2015
NWAP
NEW APPLICATION ENTERED
10/14/2015
Continuous trademark protection
Get notified about every new filing that threatens CPIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.